Corticosteroid treatment in the management of idiopathic granulomatous mastitis to avoid unnecessary surgery
- 660 Downloads
Idiopathic granulomatous mastitis (IGM) is a rare benign inflammatory disease of the breast. It can mimic breast carcinoma clinically and radiologically, and usually affects females of childbearing age. There is no commonly accepted optimal treatment for IGM. In this study, we present the clinical and histopathological features and outcomes of the therapeutic management of IGM, as well as the clinical course of the disease when patients were treated with oral corticosteroids.
This retrospective study included 49 of 87 patients who met the required histological criteria for IGM who were followed up between January 2009 and December 2011. All patients had a disease-free follow-up period of at least 6 months. The data regarding the clinical features at presentation, laboratory values and the treatment modalities were obtained from the medical records of the patients.
The mean age of the patients was 34.3 ± 4.37 years. Forty patients were treated with prednisolone, five were started on antituberculosis treatment, two received non-steroidal anti-inflammatory drugs, one received antibiotics and one underwent wide excision. All patients who received steroids responded well to the therapy.
Systemic therapy with corticosteroids is an effective and appropriate treatment option for IGM. It can provide complete disease resolution and prevent recurrence in the long term. A multidisciplinary approach including specialists in the fields of both general surgery and infectious diseases is essential for the diagnosis, treatment and follow-up of IGM.
KeywordsIdiopathic granulomatous mastitis Corticosteroid Breast neoplasms
- 2.Cohen C. Granulomatous mastitis. A review of 5 cases. South Afr Med J. Suid-Afrikaanse tydskrif vir geneeskunde. 1977;52:14–6.Google Scholar
- 5.Carmalt HL, Ramsey-Stewart G. Granulomatous mastitis. Med J Austr. 1981;1:356–9.Google Scholar
- 9.Rowe PH. Granulomatous mastitis associated with a pituitary prolactinoma. Brit J Clin Practice. 1984;38:32–4.Google Scholar
- 12.Mirsaeidi SM, Masjedi MR, Mansouri SD, Velayati AA. Tuberculosis of the breast: report of 4 clinical cases and literature review. East Mediter Health J. La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit. 2007;13:670–6.Google Scholar
- 32.Kok KY, Telisinghe PU. Granulomatous mastitis: presentation, treatment and outcome in 43 patients. Surg. 2010;8:197–201.Google Scholar
- 47.Neel A, Hello M, Cottereau A, Graveleau J, De Faucal P, Costedoat-Chalumeau N, et al. Long-term outcome in idiopathic granulomatous mastitis: a western multicentre study. QJM. 2013.Google Scholar
- 50.Ponce de Leon D, Acevedo-Vasquez E, Alvizuri S, Gutierrez C, Cucho M, Alfaro J, et al. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. J Rheumatol. 2008;35:776–81.PubMedGoogle Scholar
- 57.Boarki K, Labib M. Imaging findings in Idiopathic lobular granulomattous mastitis, case report and review of literature. Gulf J Oncol. 2010;(7):46–52.Google Scholar
- 59.Lin TL, Chi SY, Liu JW, Chou FF. Tuberculosis of the breast: 10 years’ experience in one institution. Intern J Tuberc Lung Dis. 2010;14:758–63.Google Scholar
- 61.Wilson JP, Massoll N, Marshall J, Foss RM, Copeland EM, Grobmyer SR. Idiopathic granulomatous mastitis: in search of a therapeutic paradigm. Amer Surg. 2007;73:798–802.Google Scholar
- 68.Ayeva-Derman M, Perrotin F, Lefrancq T, Roy F, Lansac J, Body G. Idiopathic granulomatous mastitis. Review of the literature illustrated by 4 cases. J Gynecol Obstet Biol Reprod. 1999;28:800–7.Google Scholar